Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6710026rdf:typepubmed:Citationlld:pubmed
pubmed-article:6710026lifeskim:mentionsumls-concept:C0005768lld:lifeskim
pubmed-article:6710026lifeskim:mentionsumls-concept:C0005795lld:lifeskim
pubmed-article:6710026lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:6710026lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:6710026lifeskim:mentionsumls-concept:C1742737lld:lifeskim
pubmed-article:6710026pubmed:issue1lld:pubmed
pubmed-article:6710026pubmed:dateCreated1984-5-24lld:pubmed
pubmed-article:6710026pubmed:abstractTextA screening of antitetanic antibody (AcAT) carriers has been carried out in 4770 blood donors. The percentage of "positive" subjects (with a rate of AcAT greater than or equal to 5 U.I./ml according to Laurell's method) is relatively high: 6,62%. The aim of a statistical study is to find out the distribution of AcAT carriers according to different factors: the chi 2 test allows us to conclude that the relation between the frequency of "positive" AcAT carriers and the blood groups is not significant but there is a significant connection between the frequency of "positive" AcAT carriers, sex and age. Our conclusions agree with those of authors having performed the study after vaccination. Our study has a double advantage: it allows us to know the vaccination state of the blood donors before any vaccination and allows the collecting of "positive" serum samples without having to wait for the vaccination.lld:pubmed
pubmed-article:6710026pubmed:languagefrelld:pubmed
pubmed-article:6710026pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6710026pubmed:citationSubsetIMlld:pubmed
pubmed-article:6710026pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6710026pubmed:statusMEDLINElld:pubmed
pubmed-article:6710026pubmed:monthFeblld:pubmed
pubmed-article:6710026pubmed:issn0338-4535lld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:SimonneauMMlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:JaulmesBBlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:FrançoisAAlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:AudatFFlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:HoangBBlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:Le XuanPPlld:pubmed
pubmed-article:6710026pubmed:authorpubmed-author:GuichouxPPlld:pubmed
pubmed-article:6710026pubmed:issnTypePrintlld:pubmed
pubmed-article:6710026pubmed:volume27lld:pubmed
pubmed-article:6710026pubmed:ownerNLMlld:pubmed
pubmed-article:6710026pubmed:authorsCompleteYlld:pubmed
pubmed-article:6710026pubmed:pagination91-5lld:pubmed
pubmed-article:6710026pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:meshHeadingpubmed-meshheading:6710026-...lld:pubmed
pubmed-article:6710026pubmed:year1984lld:pubmed
pubmed-article:6710026pubmed:articleTitle[Screening of carriers of antitetanus antibodies in blood donors].lld:pubmed
pubmed-article:6710026pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6710026pubmed:publicationTypeEnglish Abstractlld:pubmed